Mutational analysis of Rac2 in gliomas
Letter to the Editor
First Online:
Received:
Accepted:
- 61 Downloads
Keywords
Adenoma Single Nucleotide Polymorphism Meningioma Mutation Rate Astrocytoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Notes
Acknowledgements
This work was supported by grants from the INSERM, and the Carte d’Identité des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer.
References
- 1.Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629–635PubMedCrossRefGoogle Scholar
- 2.Sun D, Xu D, Zhang B (2006) Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 9:274–287PubMedCrossRefGoogle Scholar
- 3.Hwang SL et al (2005) Rac2 expression and mutation in human brain tumors. Acta Neurochir (Wien) 147:551–554CrossRefGoogle Scholar
- 4.Akbar H et al (2006) Rational design and applications of a Rac GTPase-specific small molecule inhibitor. Methods Enzymol 406:554–565PubMedCrossRefGoogle Scholar
- 5.Bamford S et al (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91(2):355–358PubMedGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC. 2008